0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Injection Immunoglobulin Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6G8570
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intravenous Injection Immunoglobulin Market Insights Forecast to 2028
BUY CHAPTERS

Global Intravenous Injection Immunoglobulin Market Research Report 2025

Code: QYRE-Auto-6G8570
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intravenous Injection Immunoglobulin Market

The global market for Intravenous Injection Immunoglobulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Intravenous Injection Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Intravenous Injection Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Intravenous Injection Immunoglobulin include Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB, Nanyue Biopharming, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Injection Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Injection Immunoglobulin.
The Intravenous Injection Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Injection Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Injection Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous Injection Immunoglobulin Market Report

Report Metric Details
Report Name Intravenous Injection Immunoglobulin Market
Segment by Type
  • 1g/20ml
  • 1.25g/25ml
  • 2.5g/50ml
  • 5g/100ml
  • 10g/200ml
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB, Nanyue Biopharming
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intravenous Injection Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intravenous Injection Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Intravenous Injection Immunoglobulin Market report?

Ans: The main players in the Intravenous Injection Immunoglobulin Market are Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB, Nanyue Biopharming

What are the Application segmentation covered in the Intravenous Injection Immunoglobulin Market report?

Ans: The Applications covered in the Intravenous Injection Immunoglobulin Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Intravenous Injection Immunoglobulin Market report?

Ans: The Types covered in the Intravenous Injection Immunoglobulin Market report are 1g/20ml, 1.25g/25ml, 2.5g/50ml, 5g/100ml, 10g/200ml

1 Intravenous Injection Immunoglobulin Market Overview
1.1 Product Definition
1.2 Intravenous Injection Immunoglobulin by Type
1.2.1 Global Intravenous Injection Immunoglobulin Market Value Comparison by Type (2024 VS 2031)
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.3 Intravenous Injection Immunoglobulin by Application
1.3.1 Global Intravenous Injection Immunoglobulin Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Intravenous Injection Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Intravenous Injection Immunoglobulin Revenue 2020-2031
1.4.2 Global Intravenous Injection Immunoglobulin Sales 2020-2031
1.4.3 Global Intravenous Injection Immunoglobulin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous Injection Immunoglobulin Market Competition by Manufacturers
2.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous Injection Immunoglobulin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous Injection Immunoglobulin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous Injection Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Injection Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Injection Immunoglobulin, Product Type & Application
2.7 Global Key Manufacturers of Intravenous Injection Immunoglobulin, Date of Enter into This Industry
2.8 Global Intravenous Injection Immunoglobulin Market Competitive Situation and Trends
2.8.1 Global Intravenous Injection Immunoglobulin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous Injection Immunoglobulin Players Market Share by Revenue
2.8.3 Global Intravenous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Injection Immunoglobulin Market Scenario by Region
3.1 Global Intravenous Injection Immunoglobulin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous Injection Immunoglobulin Sales by Region: 2020-2031
3.2.1 Global Intravenous Injection Immunoglobulin Sales by Region: 2020-2025
3.2.2 Global Intravenous Injection Immunoglobulin Sales by Region: 2026-2031
3.3 Global Intravenous Injection Immunoglobulin Revenue by Region: 2020-2031
3.3.1 Global Intravenous Injection Immunoglobulin Revenue by Region: 2020-2025
3.3.2 Global Intravenous Injection Immunoglobulin Revenue by Region: 2026-2031
3.4 North America Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Intravenous Injection Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous Injection Immunoglobulin Sales by Country (2020-2031)
3.4.3 North America Intravenous Injection Immunoglobulin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Intravenous Injection Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous Injection Immunoglobulin Sales by Country (2020-2031)
3.5.3 Europe Intravenous Injection Immunoglobulin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Injection Immunoglobulin Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Injection Immunoglobulin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous Injection Immunoglobulin Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Intravenous Injection Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous Injection Immunoglobulin Sales by Country (2020-2031)
3.7.3 Latin America Intravenous Injection Immunoglobulin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Injection Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Injection Immunoglobulin Sales by Type (2020-2031)
4.1.1 Global Intravenous Injection Immunoglobulin Sales by Type (2020-2025)
4.1.2 Global Intravenous Injection Immunoglobulin Sales by Type (2026-2031)
4.1.3 Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Injection Immunoglobulin Revenue by Type (2020-2031)
4.2.1 Global Intravenous Injection Immunoglobulin Revenue by Type (2020-2025)
4.2.2 Global Intravenous Injection Immunoglobulin Revenue by Type (2026-2031)
4.2.3 Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous Injection Immunoglobulin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous Injection Immunoglobulin Sales by Application (2020-2031)
5.1.1 Global Intravenous Injection Immunoglobulin Sales by Application (2020-2025)
5.1.2 Global Intravenous Injection Immunoglobulin Sales by Application (2026-2031)
5.1.3 Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2020-2031)
5.2 Global Intravenous Injection Immunoglobulin Revenue by Application (2020-2031)
5.2.1 Global Intravenous Injection Immunoglobulin Revenue by Application (2020-2025)
5.2.2 Global Intravenous Injection Immunoglobulin Revenue by Application (2026-2031)
5.2.3 Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous Injection Immunoglobulin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boya-Bio
6.1.1 Boya-Bio Company Information
6.1.2 Boya-Bio Description and Business Overview
6.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boya-Bio Intravenous Injection Immunoglobulin Product Portfolio
6.1.5 Boya-Bio Recent Developments/Updates
6.2 Beijing Tiantan Biological Products
6.2.1 Beijing Tiantan Biological Products Company Information
6.2.2 Beijing Tiantan Biological Products Description and Business Overview
6.2.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolio
6.2.5 Beijing Tiantan Biological Products Recent Developments/Updates
6.3 Hualan Bio
6.3.1 Hualan Bio Company Information
6.3.2 Hualan Bio Description and Business Overview
6.3.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hualan Bio Intravenous Injection Immunoglobulin Product Portfolio
6.3.5 Hualan Bio Recent Developments/Updates
6.4 Guangdong Shuagnlin Bio-pharmacy
6.4.1 Guangdong Shuagnlin Bio-pharmacy Company Information
6.4.2 Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
6.4.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolio
6.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
6.5 Weiguang Biological
6.5.1 Weiguang Biological Company Information
6.5.2 Weiguang Biological Description and Business Overview
6.5.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolio
6.5.5 Weiguang Biological Recent Developments/Updates
6.6 Sinopharm
6.6.1 Sinopharm Company Information
6.6.2 Sinopharm Description and Business Overview
6.6.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sinopharm Intravenous Injection Immunoglobulin Product Portfolio
6.6.5 Sinopharm Recent Developments/Updates
6.7 Shanghai RAAS
6.7.1 Shanghai RAAS Company Information
6.7.2 Shanghai RAAS Description and Business Overview
6.7.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolio
6.7.5 Shanghai RAAS Recent Developments/Updates
6.8 CTBB
6.8.1 CTBB Company Information
6.8.2 CTBB Description and Business Overview
6.8.3 CTBB Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CTBB Intravenous Injection Immunoglobulin Product Portfolio
6.8.5 CTBB Recent Developments/Updates
6.9 Nanyue Biopharming
6.9.1 Nanyue Biopharming Company Information
6.9.2 Nanyue Biopharming Description and Business Overview
6.9.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolio
6.9.5 Nanyue Biopharming Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Injection Immunoglobulin Industry Chain Analysis
7.2 Intravenous Injection Immunoglobulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Injection Immunoglobulin Production Mode & Process Analysis
7.4 Intravenous Injection Immunoglobulin Sales and Marketing
7.4.1 Intravenous Injection Immunoglobulin Sales Channels
7.4.2 Intravenous Injection Immunoglobulin Distributors
7.5 Intravenous Injection Immunoglobulin Customer Analysis
8 Intravenous Injection Immunoglobulin Market Dynamics
8.1 Intravenous Injection Immunoglobulin Industry Trends
8.2 Intravenous Injection Immunoglobulin Market Drivers
8.3 Intravenous Injection Immunoglobulin Market Challenges
8.4 Intravenous Injection Immunoglobulin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Intravenous Injection Immunoglobulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intravenous Injection Immunoglobulin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intravenous Injection Immunoglobulin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intravenous Injection Immunoglobulin Sales (L) of Key Manufacturers (2020-2025)
 Table 5. Global Intravenous Injection Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intravenous Injection Immunoglobulin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intravenous Injection Immunoglobulin Average Price (US$/ml) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intravenous Injection Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intravenous Injection Immunoglobulin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intravenous Injection Immunoglobulin, Product Type & Application
 Table 12. Global Key Manufacturers of Intravenous Injection Immunoglobulin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravenous Injection Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Injection Immunoglobulin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous Injection Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intravenous Injection Immunoglobulin Sales by Region (2020-2025) & (L)
 Table 18. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2020-2025)
 Table 19. Global Intravenous Injection Immunoglobulin Sales by Region (2026-2031) & (L)
 Table 20. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2026-2031)
 Table 21. Global Intravenous Injection Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2020-2025)
 Table 23. Global Intravenous Injection Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2026-2031)
 Table 25. North America Intravenous Injection Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intravenous Injection Immunoglobulin Sales by Country (2020-2025) & (L)
 Table 27. North America Intravenous Injection Immunoglobulin Sales by Country (2026-2031) & (L)
 Table 28. North America Intravenous Injection Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intravenous Injection Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intravenous Injection Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intravenous Injection Immunoglobulin Sales by Country (2020-2025) & (L)
 Table 32. Europe Intravenous Injection Immunoglobulin Sales by Country (2026-2031) & (L)
 Table 33. Europe Intravenous Injection Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intravenous Injection Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intravenous Injection Immunoglobulin Sales by Region (2020-2025) & (L)
 Table 37. Asia Pacific Intravenous Injection Immunoglobulin Sales by Region (2026-2031) & (L)
 Table 38. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intravenous Injection Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intravenous Injection Immunoglobulin Sales by Country (2020-2025) & (L)
 Table 42. Latin America Intravenous Injection Immunoglobulin Sales by Country (2026-2031) & (L)
 Table 43. Latin America Intravenous Injection Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intravenous Injection Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2020-2025) & (L)
 Table 47. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2026-2031) & (L)
 Table 48. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intravenous Injection Immunoglobulin Sales (L) by Type (2020-2025)
 Table 51. Global Intravenous Injection Immunoglobulin Sales (L) by Type (2026-2031)
 Table 52. Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2020-2025)
 Table 53. Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2026-2031)
 Table 54. Global Intravenous Injection Immunoglobulin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intravenous Injection Immunoglobulin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2020-2025)
 Table 57. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2026-2031)
 Table 58. Global Intravenous Injection Immunoglobulin Price (US$/ml) by Type (2020-2025)
 Table 59. Global Intravenous Injection Immunoglobulin Price (US$/ml) by Type (2026-2031)
 Table 60. Global Intravenous Injection Immunoglobulin Sales (L) by Application (2020-2025)
 Table 61. Global Intravenous Injection Immunoglobulin Sales (L) by Application (2026-2031)
 Table 62. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2020-2025)
 Table 63. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2026-2031)
 Table 64. Global Intravenous Injection Immunoglobulin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intravenous Injection Immunoglobulin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2020-2025)
 Table 67. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2026-2031)
 Table 68. Global Intravenous Injection Immunoglobulin Price (US$/ml) by Application (2020-2025)
 Table 69. Global Intravenous Injection Immunoglobulin Price (US$/ml) by Application (2026-2031)
 Table 70. Boya-Bio Company Information
 Table 71. Boya-Bio Description and Business Overview
 Table 72. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 73. Boya-Bio Intravenous Injection Immunoglobulin Product
 Table 74. Boya-Bio Recent Developments/Updates
 Table 75. Beijing Tiantan Biological Products Company Information
 Table 76. Beijing Tiantan Biological Products Description and Business Overview
 Table 77. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 78. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product
 Table 79. Beijing Tiantan Biological Products Recent Developments/Updates
 Table 80. Hualan Bio Company Information
 Table 81. Hualan Bio Description and Business Overview
 Table 82. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 83. Hualan Bio Intravenous Injection Immunoglobulin Product
 Table 84. Hualan Bio Recent Developments/Updates
 Table 85. Guangdong Shuagnlin Bio-pharmacy Company Information
 Table 86. Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
 Table 87. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 88. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product
 Table 89. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
 Table 90. Weiguang Biological Company Information
 Table 91. Weiguang Biological Description and Business Overview
 Table 92. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 93. Weiguang Biological Intravenous Injection Immunoglobulin Product
 Table 94. Weiguang Biological Recent Developments/Updates
 Table 95. Sinopharm Company Information
 Table 96. Sinopharm Description and Business Overview
 Table 97. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 98. Sinopharm Intravenous Injection Immunoglobulin Product
 Table 99. Sinopharm Recent Developments/Updates
 Table 100. Shanghai RAAS Company Information
 Table 101. Shanghai RAAS Description and Business Overview
 Table 102. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 103. Shanghai RAAS Intravenous Injection Immunoglobulin Product
 Table 104. Shanghai RAAS Recent Developments/Updates
 Table 105. CTBB Company Information
 Table 106. CTBB Description and Business Overview
 Table 107. CTBB Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 108. CTBB Intravenous Injection Immunoglobulin Product
 Table 109. CTBB Recent Developments/Updates
 Table 110. Nanyue Biopharming Company Information
 Table 111. Nanyue Biopharming Description and Business Overview
 Table 112. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
 Table 113. Nanyue Biopharming Intravenous Injection Immunoglobulin Product
 Table 114. Nanyue Biopharming Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Intravenous Injection Immunoglobulin Distributors List
 Table 118. Intravenous Injection Immunoglobulin Customers List
 Table 119. Intravenous Injection Immunoglobulin Market Trends
 Table 120. Intravenous Injection Immunoglobulin Market Drivers
 Table 121. Intravenous Injection Immunoglobulin Market Challenges
 Table 122. Intravenous Injection Immunoglobulin Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravenous Injection Immunoglobulin
 Figure 2. Global Intravenous Injection Immunoglobulin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intravenous Injection Immunoglobulin Market Share by Type: 2024 & 2031
 Figure 4. 1g/20ml Product Picture
 Figure 5. 1.25g/25ml Product Picture
 Figure 6. 2.5g/50ml Product Picture
 Figure 7. 5g/100ml Product Picture
 Figure 8. 10g/200ml Product Picture
 Figure 9. Global Intravenous Injection Immunoglobulin Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Intravenous Injection Immunoglobulin Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Others
 Figure 14. Global Intravenous Injection Immunoglobulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Intravenous Injection Immunoglobulin Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Intravenous Injection Immunoglobulin Sales (2020-2031) & (L)
 Figure 17. Global Intravenous Injection Immunoglobulin Average Price (US$/ml) & (2020-2031)
 Figure 18. Intravenous Injection Immunoglobulin Report Years Considered
 Figure 19. Intravenous Injection Immunoglobulin Sales Share by Manufacturers in 2024
 Figure 20. Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Intravenous Injection Immunoglobulin Players: Market Share by Revenue in Intravenous Injection Immunoglobulin in 2024
 Figure 22. Intravenous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Intravenous Injection Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Intravenous Injection Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 25. North America Intravenous Injection Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 29. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Intravenous Injection Immunoglobulin Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Region (2020-2031)
 Figure 37. China Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Intravenous Injection Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Intravenous Injection Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Intravenous Injection Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Intravenous Injection Immunoglobulin by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Intravenous Injection Immunoglobulin by Type (2020-2031)
 Figure 59. Global Intravenous Injection Immunoglobulin Price (US$/ml) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Intravenous Injection Immunoglobulin by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Intravenous Injection Immunoglobulin by Application (2020-2031)
 Figure 62. Global Intravenous Injection Immunoglobulin Price (US$/ml) by Application (2020-2031)
 Figure 63. Intravenous Injection Immunoglobulin Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona